Episode
How a Stanford aging biologist invests in longevity - Dr. Alex Colville
- Podcast
- Free Radicals
- Published
- Nov 25, 2025
- Duration seconds
- 4865
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/free-radicals-7588534/episodes/how-a-stanford-aging-biologist-invests-in-longevity-dr-alex-colville/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/free-radicals-7588534/how-a-stanford-aging-biologist-invests-in-longevity-dr-alex-colville.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Alex Colville, PhD, is a Co-founder and General Partner at Age1, one of the premier aging venture capital firms where he has invested in companies like Science, Gordian, Loyal, and General Control. Prior to that, he was an investor and founding chief of staff at Amaranth Foundation, where he invested in moonshot biology and aging initiatives. He got his biotech business career started as a management consultant at Putnam Associates and as a consultant to the Maze Therapeutics BD team and Rubedo Life Sciences R&D team. Alex earned his PhD at Stanford in the biology of aging.